Catalent has completed a $10 million expansion in state-of-the-art large-scale isolator units at its Malvern, PA, and Dartford, UK, facilities, to provide advanced containment capabilities for the micronization of highly potent drug compounds.   The new hard-wall isolator systems at both sites allow for clinical to commercial scale jet milling operations to be carried out under enhanced containment conditions, with occupational exposure limit (OEL) values as low as 0.05 micrograms per cubic me...